388 related articles for article (PubMed ID: 36774403)
21. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
22. Exoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a retrospective single-center study on 388 patients.
Sumisławski P; Piffko A; Huckhagel T; Ryba A; Burkhardt T; Aberle J; Saeger W; Flitsch J; Rotermund R
Neurosurg Rev; 2022 Dec; 45(6):3675-3681. PubMed ID: 36136255
[TBL] [Abstract][Full Text] [Related]
23. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
24. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.
Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P
Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
[TBL] [Abstract][Full Text] [Related]
26. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
27. Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.
Paľa A; Etzrodt-Walter G; Karpel-Massler G; Pedro MT; Mayer B; Coburger J; Wirtz CR; Hlaváč M
Neurosurg Rev; 2022 Apr; 45(2):1701-1708. PubMed ID: 34855027
[TBL] [Abstract][Full Text] [Related]
28. Radiographic and clinical outcomes using intraoperative magnetic resonance imaging for transsphenoidal resection of pituitary adenomas.
Juthani RG; Reiner AS; Patel AR; Cowan A; Roguski M; Panageas KS; Geer EB; Karimi S; Cohen MA; Tabar V
J Neurosurg; 2020 Jul; 134(6):1824-1835. PubMed ID: 32619972
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
Koutourousiou M; Gardner PA; Fernandez-Miranda JC; Paluzzi A; Wang EW; Snyderman CH
J Neurosurg; 2013 Mar; 118(3):621-31. PubMed ID: 23289816
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.
Kim JH; Lee JH; Lee JH; Hong AR; Kim YJ; Kim YH
World Neurosurg; 2018 Jan; 109():e409-e416. PubMed ID: 29017983
[TBL] [Abstract][Full Text] [Related]
31. Outcome of Endoscopic Transsphenoidal Surgery for Recurrent or Residual Pituitary Adenomas and Comparison to Non-Recurrent or Residual Cohort by Propensity Score Analysis.
Gong X; Zhuo Y; Yuan H; Yang K; Li C; Feng S; Zhang M; Li Z; Zhou H; Liu Z
Front Endocrinol (Lausanne); 2022; 13():837025. PubMed ID: 35547003
[TBL] [Abstract][Full Text] [Related]
32. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
33. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.
Locatelli D; Veiceschi P; Castelnuovo P; Tanriover N; Evliyaoglu O; Canaz H; Ugurlar D; Gazioglu N
Childs Nerv Syst; 2019 Nov; 35(11):2119-2126. PubMed ID: 31079182
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
[TBL] [Abstract][Full Text] [Related]
35. Fully endoscopic combined transsphenoidal and supraorbital keyhole approach for parasellar lesions.
Nagata Y; Watanabe T; Nagatani T; Takeuchi K; Chu J; Wakabayashi T
J Neurosurg; 2018 Mar; 128(3):685-694. PubMed ID: 28452613
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
37. Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.
Lee MH; Hur KY; Hong SD; Seol HJ; Choi JW; Lee JI; Nam DH; Kong DS
J Neurooncol; 2021 Jun; 153(2):343-350. PubMed ID: 34002303
[TBL] [Abstract][Full Text] [Related]
38. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
McLaughlin N; Eisenberg AA; Cohan P; Chaloner CB; Kelly DF
J Neurosurg; 2013 Mar; 118(3):613-20. PubMed ID: 23240699
[TBL] [Abstract][Full Text] [Related]
39. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
40. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
